Medical Regulation

Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.

Despite ethical concerns, scholar argues that gene editing of human embryos should not be banned.

Scholar argues that FDA should reform its regulation of algorithm-based medicine.

In keynote address, Gary Marchant discusses the transnational implications of genetic engineering.

Policymakers should consider the impact of their decisions on not just wealth, but also human life.

FDA should encourage states to be the primary regulators of stem cell procedures.

Regulatory capture, neither inevitable nor a death trap for agencies, must be reduced to advance public policy goals.

A French agency’s report on the Germanwings accident reassesses the balance between medical privacy and public safety.

Court finds state law to be medically unnecessary and burdensome to women seeking abortion services.

Scholar argues against proposal to regulate lab-developed tests as medical devices.

Scholar argues in favor of proposal to regulate lab-developed tests as medical devices.

Professor suggests regulation could dispel common objections to selling organs.